Thyroid carcinoma in the McCune-Albright syndrome: Contributory role of activating Gsα mutations

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4413-4417

  Collins, Michael T ^a   Sarlis, Nicholas J ^b,g   Merino, Maria J ^c   Monroe, Jason ^e   Crawford, Susan E ^f   Krakoff, Jonathan A ^b   Guthrie, Lori C ^b   Bonat, Sandra ^d   Robey, Pamela G ^a   Shenker, Andrew ^e,h  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE;

ACTIVATING MUTATION IN THE GENE 1; ADOLESCENT; ADULT; ALBRIGHT SYNDROME; ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE MUTATION; GENETIC STRAIN; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID HYPERPLASIA; THYROIDECTOMY;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ADULT; CARCINOMA, PAPILLARY; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; GENES, RAS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MUTATION; NERVE TISSUE PROTEINS; PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; THYROIDECTOMY;

POMACANTHUS MACULOSUS;

EID: 0141452998     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021642     Document Type: Article

References (41)

1. Danon M, Crawford JD 1987 The McCune-Albright syndrome. Ergeb Inn Med Kinderheilkd 55:81-115
2. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, Van Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM 1993 Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr 123:509-518
3. Okamoto S, Hisaoka M, Ushijima M, Nakahara S, Toyoshima S, Hashimoto H 2000 Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Arch 437:133-137
4. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG 2001 Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor- induced osteomalacia. J Bone Miner Res 16:806-813
5. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695
6. Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R, Feunteun J 1994 Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA 91:10488-10492
7. Collins MT, Shenker A 1999 McCune-Albright syndrome: new insights. Curr Opin Endocrinol Diabetes 6:119-125
8. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L 1989 GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692-696
9. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655-659
10. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M 1993 Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis. Cancer 72:1386-1393
11. Riminucci M, Collins MT, Lala R, Corsi A, Matarazzo P, Gehron Robey P, Bianco P 2002 An R201H activating mutation of the GNAS1 (Gsá) gene in a corticotroph pituitary adenoma. Mol Pathol 55:58-60
12. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog 4:345-349
13. Suarez HG 1998 Genetic alterations in human epithelial thyroid tumours. Clin Endocrinol (Oxf) 48:531-546
14. Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS, Frazzatto ET, Mendonca BB, Villares SM 1998 Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab 83:2074-2078
15. Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, Corsi A, Bone HG, Wientroub S, Spiegel AM, Fisher LW, Robey PG 2000 Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15:120-128
16. Pienkowski C, Lumbroso S, Bieth E, Sultan C, Rochiccioli P, Tauber M 1997 Recurrent ovarian cyst and mutation of the Gsá gene in ovarian cyst fluid cells: what is the link with McCune-Albright syndrome? Acta Paediatr 86:1019-1021
17. Feuillan PP, Shawker T, Rose SR, Jones J, Jeevanram RK, Nisula BC 1990 Thyroid abnormalities in the McCune-Albright syndrome: ultrasonography and hormonal studies. J Clin Endocrinol Metab 71:1596-1601
18. Mastorakos G, Mitsiades NS, Doufas AG, Koutras DA 1997 Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 7:433-439
19. Yang GC, Yao JL, Feiner HD, Roses DF, Kumar A, Mulder JE 1999 Lipid-rich follicular carcinoma of the thyroid in a patient with McCune-Albright syndrome. Mod Pathol 12:969-973
20. Seligman S 1992 McCune-Albright syndrome. J Bellevue Obstet Gynecol Soc 8:56
21. Lopez-Ben R, Pitt MJ, Jaffe KA, Siegal GP 1999 Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome. Skeletal Radiol 28:522-526
22. Sarkar FH, Li YW, Crissman JD 1993 A method for PCR sequencing of the p53 gene from a single 10-micron frozen or paraffin-embedded tissue section. Biotechniques 15:36-38
23. Eggerding FA 2000 Fluorescent oligonucleotide ligation technology for identification of ras oncogene mutations. Mol Biotechnol 14:223-233
24. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL 2001 Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 14:338-342
25. Esapa C, Foster S, Johnson S, Jameson JL, Kendall-Taylor P, Harris PE 1997 G protein and thyrotropin receptor mutations in thyroid neoplasia. J Clin Endocrinol Metab 82:493-496
26. Park KY, Koh JM, Kim YI, Park HJ, Gong G, Hong SJ, Ahn IM 1998 Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population. Clin Endocrinol (Oxf) 4:317-323
27. Bourasseau I, Savagner F, Rodien P, Duquenne M, Reynier P, Guyetant S, Bigorgne JC, Malthiery Y, Rohmer V 2000 No evidence of thyrotropin receptor and G(s alpha) gene mutation in high iodine uptake thyroid carcinoma. Thyroid 10:761-765
28. Mircescu H, Parma J, Huot C, Deal C, Oligny LL, Vassart G, Van Vliet G 2000 Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: pathologic and molecular studies. J Pediatr 137:585-587
29. Zeiger MA, Saji M, Gusev Y, Westra WH, Takiyama Y, Dooley WC, Kohn LD, Levine MA 1997 Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology 138:3133-3140
30. Coppee F, Gerard AC, Denef JF, Ledent C, Vassart G, Dumont JE, Parmentier M 1996 Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene. Oncogene 13:1471-1482
31. Wynford-Thomas D 1997 Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res 47:145-157
32. Cooper DS, Axelrod L, DeGroot LJ, Vickery Jr AL, Maloof F 1981 Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of nonhormonal iodide: clinical, pathological, kinetic, and biochemical studies and a review of the literature. J Clin Endocrinol Metab 52:294-306
33. Medeiros-Neto G, Gil-Da-Costa MJ, Santos CL, Medina AM, Silva JC, Tsou RM, Sobrinho-Simoes M 1998 Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene. J Clin Endocrinol Metab 83:4162-4166
34. Civantos F, Albores-Saavedra J, Nadji M, Morales AR 1984 Clear cell variant of thyroid carcinoma. Am J Surg Pathol 8:187-192
35. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A 1999 Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341:1731-1736
36. Ringel MD, Saji M, Schwindinger WF, Segev D, Zeiger MA, Levine MA 1998 Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia. J Clin Endocrinol Metab 83:554-559
37. Blanco P, Schaeverbeke T, Baillet L, Lequen L, Bannwarth B, Dehais J 1999 Chondrosarcoma in a patient with McCune-Albright syndrome. Report of a case. Rev Rhum Engl Ed 66:177-179
38. Ruggieri P, Sim FH, Bond JR, Unni KK 1994 Malignancies in fibrous dysplasia. Cancer 73:1411-1424
39. Tanabeu Y, Nakahara S, Mitsuyama S, Ono M, Toyoshima S 1998 Breast cancer in a patient with McCune-Albright syndrome. Breast Cancer 5:175-178
40. Scanlon EF, Burkett FE, Sener SF, Green OC, Traisman HS, Marr TJ, Victor TA, Crist ML 1980 Breast carcinoma in a 11-year-old girl with Albright's syndrome. Breast 6:6-9
41. Fagin JA 2002 Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 16:903-911